SavedAdd your journal

Journals / Marmara Medical Journal / 2016 / Cilt: 29 - Sayı: 2

Immune mechanisms in chronic viral hepatitis

Filiz Türe ÖZDEMİR
Pages
2–5
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hereby, we present theimmune mechanisms and immunopathogenesis involved inchronic viral hepatitis.Keywords: HBV, HCV, Innate immunity, Adaptiveimmunity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatitis B virus (HBV) and Hepatitis C virus (HCV) arethe major causes of chronic liver inflammation worldwide.Although both viruses induce immune-mediated acute andchronic inflammatory liver diseases, the natural history andoutcome of HBV and HCV infections are different.
📊
Key Findings & Data:Thisis because of both viruses and host features, like genetic,immunologic and environmental.
💡
Conclusion & Impact:Hereby, we present theimmune mechanisms and immunopathogenesis involved inchronic viral hepatitis.Keywords: HBV, HCV, Innate immunity, Adaptiveimmunity
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hepatitis B virus (HBV) and Hepatitis C virus (HCV) arethe major causes of chronic liver inflammation worldwide.Although both viruses induce immune-mediated acute andchronic inflammatory liver diseases, the natural history andoutcome of HBV and HCV infections are different. Thisis because of both viruses and host features, like genetic,immunologic and environmental. Hereby, we present theimmune mechanisms and immunopathogenesis involved inchronic viral hepatitis.Keywords: HBV, HCV, Innate immunity, Adaptiveimmunity

Özet

Hepatitis B virus (HBV) and Hepatitis C virus (HCV) arethe major causes of chronic liver inflammation worldwide.Although both viruses induce immune-mediated acute andchronic inflammatory liver diseases, the natural history andoutcome of HBV and HCV infections are different. Thisis because of both viruses and host features, like genetic,immunologic and environmental. Hereby, we present theimmune mechanisms and immunopathogenesis involved inchronic viral hepatitis.Keywords: HBV, HCV, Innate immunity, Adaptiveimmunity

🔖

Cite This Article

ÖZDEMİR, F. T. (2016). Immune mechanisms in chronic viral hepatitis. Marmara Medical Journal, Cilt: 29 - Sayı: 2, 2–5. https://ajindex.com/articles/283853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 34: 1225–41.
  2. Ganem D, Prince AM. Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med 2004; 350 –29. Guidotti LG, Rochford R,Chung J, Shapiro M, Purcell R Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284: 825–9. Rosenberg W. Mechanisms of immune escape in viral hepatitis. Gut 1999; 44: 759–64.
  3. McClary H, Koch R, Chisari FV, Guidotti LG. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol 2000; 74: 2255– Wieland S F, Guidotti LG,M Chisari FV. Intrahepatic induction of α/β interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J. Virol 2000 4165–73.
  4. Robek MD, Wieland SF, Chisari FV. Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J. Virol 2002; 76: 3570–4.
  5. Kakimi K, Lane E, Chisari FV, Guidotti LG. Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol 167: 6701–5.
  6. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002; 16: 583–94.
  7. Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4: 35-6.
  8. Guidotti LG, Isogawa M, Chisari FV. Host–virus interactions in hepatitis B virus infection. Current Opinion in Immunology 36: 61–6.
  9. Schurich A, Khanna P, Lopes AR, et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011; 53: 1494-503.
  10. Nebbia G, Peppa D, Schurich A, et al. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One 2012; 7:e47648. Ferrari C. HBV and the immune response. Liver Int 2015 (Suppl. 1): 121-8.
  11. Billerbeck E, Bottler T, Thimme R. Regulatory T cells in viral hepatitis. World J Gastroenterol 2007; 13: 4858-64.
  12. Pallett LJ, Gill US, Quaglia A, et al. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat Med 2015; 21: 591-600.
  13. Das A, Ellis G, Pallant C, et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infec